Analystreport

Iterum Therapeutics PLC (NASDAQ: ITRM) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Iterum Therapeutics plc - Ordinary Share  (ITRM) 
Last iterum therapeutics plc - ordinary share earnings: 11/12 04:30 pm Check Earnings Report